Literature DB >> 12949529

Retraction: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids.

Alexander Kugler, Gernot Stuhler, Peter Walden, Gerhard Zöller, Anke Zobywalski, Peter Brossart, Uwe Trefzer, Silke Ullrich, Claudia A Müller, Volker Becker, Andreas J Gross, Bernhard Hemmerlein, Lothar Kanz, Gerhard A Müller, Rolf-Hermann Ringert.   

Abstract

Entities:  

Year:  2003        PMID: 12949529     DOI: 10.1038/nm0903-1221a

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  When to retract?

Authors:  Richard Smith
Journal:  BMJ       Date:  2003-10-18

Review 2.  [What can we learn from the Scott Reuben case? Scientific misconduct in anaesthesiology].

Authors:  H L Rittner; P Kranke; M Schäfer; N Roewer; A Brack
Journal:  Anaesthesist       Date:  2009-12       Impact factor: 1.041

Review 3.  Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.

Authors:  Bernhard Frankenberger; Sybille Regn; Christiane Geiger; Elfriede Noessner; Christine S Falk; Heike Pohla; Miran Javorovic; Tobias Silberzahn; Susanne Wilde; Alexander Buchner; Michael Siebels; Ralph Oberneder; Gerald Willimsky; Antonio Pezzutto; Thomas Blankenstein; Dolores J Schendel
Journal:  World J Urol       Date:  2005-07-05       Impact factor: 4.226

Review 4.  Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer.

Authors:  E Ranieri; M Gigante; W J Storkus; L Gesualdo
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.